Monopar Therapeutics Inc. (NASDAQ:MNPR) Short Interest Down 21.6% in May
Monopar Therapeutics Inc. (NASDAQ:MNPR – Get Free Report) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 62,600 shares, a decrease of 21.6% from the May 15th total of 79,800 shares. Approximately 0.7% of the shares of the company are sold short. Based […]
More Stories
Oshkosh Co. (NYSE:OSK) Receives $125.79 Consensus PT from Analysts
Shares of Oshkosh Co. (NYSE:OSK – Get Free Report) have been given an average rating of “Hold” by the fourteen...
Redeia Corporación (OTCMKTS:RDEIY) versus Barratt Developments (OTCMKTS:BTDPY) Head-To-Head Review
Barratt Developments (OTCMKTS:BTDPY – Get Free Report) and Redeia Corporación (OTCMKTS:RDEIY – Get Free Report) are both finance companies, but...
Analyzing Lithia Motors (NYSE:LAD) & D’Ieteren Group (OTCMKTS:SIEVF)
Lithia Motors (NYSE:LAD – Get Free Report) and D’Ieteren Group (OTCMKTS:SIEVF – Get Free Report) are both retail/wholesale companies, but...
Short Interest in T Stamp Inc. (NASDAQ:IDAI) Increases By 57.5%
T Stamp Inc. (NASDAQ:IDAI – Get Free Report) was the recipient of a large growth in short interest in the...
Short Interest in InMed Pharmaceuticals Inc. (NASDAQ:INM) Expands By 55.3%
InMed Pharmaceuticals Inc. (NASDAQ:INM – Get Free Report) was the recipient of a large increase in short interest during the...
Barclays Increases Cintas (NASDAQ:CTAS) Price Target to $245.00
Cintas (NASDAQ:CTAS – Get Free Report) had its target price upped by Barclays from $210.00 to $245.00 in a research...